Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending May 2012. The report details a specific corporate action regarding share repurchases executed on May 18, 2012, pursuant to shareholder authority granted at the Annual General Meeting on May 3, 2012.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure changes related to share buybacks.
- Shares Purchased: 1,600,000 Ordinary shares of 25 pence each.
- Price Range: Highest price paid was 1,410 pence per share; lowest price paid was 1,401 pence per share.
- Treasury Holdings (Settled): 531,747,927 shares (9.56% of total issued share capital).
- Treasury Holdings (Including Unsettled): 536,147,927 shares (10.65% of current total voting rights).
- Shares in Issue (Excluding Treasury): 5,032,893,045 shares.
Material Changes
The primary material change reported is the reduction of outstanding shares through the purchase of 1,600,000 shares for Treasury. Consequently, the percentage of shares held in Treasury increased to 10.65% of total voting rights when including unsettled purchases.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a compliance announcement confirming conformity with the Financial Services Authority's Disclosure and Transparency Rules and explicitly states it does not constitute an offer to purchase securities.
Investor Verification Checklist
- Verify the total number of shares held in Treasury (531,747,927 settled) against the company's latest capitalization table.
- Confirm the impact of the 10.65% Treasury holding on total voting rights calculations.
- Review the remaining authority under the May 3, 2012 shareholder mandate for future repurchases.
- Note that this filing does not contain operational or financial performance data for the period.